Alkem Laboratories (ALKEM): ALKEM Share Price Falls 2.02% to Rs 5,052.00 as Large Cap Stock Declines Today
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
ALKEM Share Price declined on 28 October 2026, with the stock last traded at Rs 5,052.00 as of 28 October 2026 at 11:22:52 AM IST. That is a fall of 2.02% from the previous close of Rs 5,156.00, or Rs 104.00 per share. The Large Cap company has a market capitalisation of Rs 60,452.06 crore.
ALKEM Stock News today is about price action alone. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for today’s fall. Alkem Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry, and the move is a single-day decline.
On the important financial metrics, Univest data shows a P/E ratio of 28.57, a P/B ratio of 4.31, ROE of 18.29% and ROCE of 21.28%. Readers following the ALKEM Stock Falling Today move can monitor how the price behaves inside the day’s range of Rs 5,011.50 to Rs 5,060.70 and how its valuation compares with industry peers, which the sections below cover.
Alkem Laboratories (ALKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,052 |
| Previous Close | Rs 5,156 |
| Today's Move | -Rs 104.00 (-2.02%) |
| Open | Rs 5,060.7 |
| High | Rs 5,060.7 |
| Low | Rs 5,011.5 |
| Market Capitalisation | Rs 60,452.06 crore |
| Market Cap Category | Large Cap |
What happened to the ALKEM Share Price today? The stock opened at Rs 5,060.70 against a previous close of Rs 5,156.00, touched a high of Rs 5,060.70 and a low of Rs 5,011.50, and was trading at Rs 5,052.00 as of 28 October 2026 at 11:22:52 AM IST, a decline of 2.02%, or Rs 104.00 per share.
The opening level of Rs 5,060.70 was Rs 95.30 below the previous close, so the stock began the day lower. The day high of Rs 5,060.70 is the same level as the open, which means the stock has traded at no higher price than its opening level so far. It then moved down to the day’s low of Rs 5,011.50, which is Rs 49.20 below the open and Rs 144.50 below the previous close.
The latest price of Rs 5,052.00 is Rs 8.70 below the open and Rs 40.50 above the day’s low, and the full range between the day’s high and low spans Rs 49.20. This ALKEM Share Price Fall comes with a market capitalisation of Rs 60,452.06 crore, and the company is classed as Large Cap. Market capitalisation describes company size, not quality, so it is background to the price move rather than an explanation of it.
Readers tracking ALKEM Share Price Live can compare the latest price with the opening level of Rs 5,060.70 and the previous close of Rs 5,156.00. With the price data laid out, the next section turns to fundamentals.
Alkem Laboratories (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 60,452.06 crore |
| P/E Ratio | 28.57x |
| P/B Ratio | 4.31x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.03% |
Alkem Laboratories (ALKEM) fundamental metrics show P/E 28.57x, P/B 4.31x, ROE 18.29%, ROCE 21.28%. Read together, these ratios describe the company’s position rather than a recommendation.
Alkem Laboratories has a market capitalisation of Rs 60,452.06 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.57x, P/B at 4.31x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 1.03%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.74x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 28.57x |
| Benchmark Median P/E | 30.74x |
| Benchmark Average P/E | 43.3x |
| Benchmark P/E Range | 3.21x to 577.05x |
| Company P/B Ratio | 4.31x |
| Benchmark Median P/B | 2.71x |
| Benchmark Average P/B | 3.99x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.23% |
| Benchmark Average ROE | 9.85% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.81% |
| Company Market Capitalisation | Rs 60,452.06 crore |
| Benchmark Median Market Cap | Rs 696.43 crore |
| Benchmark Average Market Cap | Rs 13,492.66 crore |
Alkem Laboratories (ALKEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alkem Laboratories (ALKEM) has a P/E ratio of 28.57x, which is below the benchmark median of 30.74x, a difference of -7.06%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Alkem Laboratories (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.23%, a difference of +62.87%. Alkem Laboratories (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.17%, a difference of +61.58%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,204.09 | 34.91 | 4.88 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,40,780 | 86.02 | 14.25 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,828.11 | 82.48 | 9.53 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,520.92 | 25.79 | 4.32 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,304.32 | 105.74 | 20.5 | 18.31 | 18.2 |
Alkem Laboratories (ALKEM) has a P/E ratio of 28.57x compared with the displayed peer median of 82.48x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 18.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Alkem Laboratories (ALKEM) has a market capitalisation of Rs 60,452.06 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching ALKEM
- The stock fell 2.02% to Rs 5,052.00 from a previous close of Rs 5,156.00.
- The day’s range runs from a low of Rs 5,011.50 to a high of Rs 5,060.70, with the open at Rs 5,060.70.
- The P/E of 28.57 is below the industry benchmark median of 30.74, while the P/B of 4.31 is above the median of 2.71.
- ROE of 18.29% and ROCE of 21.28% are above the industry benchmark medians of 11.23% and 13.17%.
- The Large Cap company has a market capitalisation of Rs 60,452.06 crore, above the benchmark median of Rs 696.43 crore.
About ALKEM
Alkem Laboratories is listed in the Pharmaceuticals & Drugs industry, within the Healthcare sector. It is classed as a Large Cap company with a market capitalisation of Rs 60,452.06 crore.
Within its same-industry benchmark of 199 companies, it sits above the median market capitalisation of Rs 696.43 crore. Its listed peers in the comparison include Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs, Cipla, Dr. Reddy’s, Mankind Pharma, Aurobindo Pharma and Lupin. Readers looking for ALKEM Company News can follow the stock on Univest for updates.
Track ALKEM Share Price on Univest
Use Alkem Laboratories (ALKEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can follow the live ALKEM Share Price on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and market insights for the stock. Univest brings these figures together in one place so that price action, valuation and peer context can be read side by side as the trading day progresses.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is ALKEM Share Price falling today?
Ans. ALKEM Share Price fell 2.02% to Rs 5,052.00 from a previous close of Rs 5,156.00. According to Univest data, the price event is confirmed, but no company-specific catalyst is established for today's fall.
What is ALKEM Share Price today?
Ans. As of 28 October 2026 at 11:22:52 AM IST, ALKEM Share Price was Rs 5,052.00, down Rs 104.00 or 2.02% from the previous close of Rs 5,156.00, after opening at Rs 5,060.70.
What are the day's high and low for ALKEM Share Price?
Ans. ALKEM Share Price touched a day high of Rs 5,060.70 and a day low of Rs 5,011.50. The stock was trading at Rs 5,052.00 at the time of writing, within that range of Rs 49.20.
What is the market capitalisation of ALKEM?
Ans. ALKEM has a market capitalisation of Rs 60,452.06 crore and is classed as Large Cap. Within its same-industry benchmark of 199 companies, the median market capitalisation is Rs 696.43 crore.
What is the P/E ratio of ALKEM?
Ans. ALKEM has a P/E ratio of 28.57 and a P/B ratio of 4.31. The same-industry benchmark median P/E is 30.74, with a range from 3.21 to 577.05, and the median P/B is 2.71.
What are the ROE and ROCE of ALKEM?
Ans. ALKEM reports ROE of 18.29% and ROCE of 21.28%. The same-industry benchmark medians are 11.23% for ROE and 13.17% for ROCE, so both company figures are above the middle of the group.
What are the EPS, book value and dividend yield of ALKEM?
Ans. ALKEM has EPS of Rs 180.45, book value of Rs 1,196.51 per share and a dividend yield of 1.03%. Dividend yield reflects the historical payout relative to the current price, and does not promise any future payout.
Which sector and industry does ALKEM belong to?
Ans. ALKEM belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. Its listed peers in the comparison include Sun Pharma, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. The stock belongs to the Healthcare sector.
How does ALKEM Share Price compare with its peers?
Ans. ALKEM has a P/E of 28.57, above three of the ten listed peers. Its ROE of 18.29% is higher than six of the ten peers, and its ROCE of 21.28% is higher than seven of the ten.
